Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Diana D. Shi, M.D.

Concepts (116)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Spinal Neoplasms220187030.910 Why?
Malignant Carcinoid Syndrome12017320.710 Why?
Palliative Care3202028810.610 Why?
Research Report120182960.600 Why?
Brain Neoplasms8202082970.520 Why?
Rectal Neoplasms120209950.510 Why?
Radiosurgery2202012130.500 Why?
Radiation Oncology120185110.480 Why?
Radiation Injuries1202012640.480 Why?
Joint Instability120186400.480 Why?
Spinal Fractures120186470.460 Why?
Neoadjuvant Therapy1202021530.430 Why?
Pain Measurement1202032740.430 Why?
Serotonin Uptake Inhibitors1201714250.380 Why?
Combined Modality Therapy2202089840.360 Why?
Medical Oncology1201816990.330 Why?
Periodicals as Topic1201814260.330 Why?
Mortality1201726620.320 Why?
Pain1202041110.310 Why?
Neoplasms42020182440.300 Why?
Patient Selection1201842970.300 Why?
Karnofsky Performance Status320202010.290 Why?
Anxiety1201732310.260 Why?
Melanoma1202053290.250 Why?
Depression1201762610.180 Why?
Transaminases120182130.180 Why?
Hydroxyindoleacetic Acid12017970.180 Why?
Flushing12017430.180 Why?
Histone Code120181480.170 Why?
Jumonji Domain-Containing Histone Demethylases120181860.170 Why?
Necrosis1202016450.160 Why?
Digestive System Surgical Procedures120205610.150 Why?
Carcinoid Tumor120172480.150 Why?
Radiotherapy, Adjuvant1202018650.140 Why?
Glioma2201829840.140 Why?
Carcinoma, Renal Cell2201826990.140 Why?
Retinoblastoma Protein120187440.140 Why?
Glutamic Acid1201811060.130 Why?
Qualitative Research1202020890.130 Why?
Kidney Neoplasms2201837470.120 Why?
Chemotherapy, Adjuvant1202033590.120 Why?
Radiotherapy Dosage1201828900.110 Why?
Gastrointestinal Neoplasms120199450.110 Why?
Spine120189800.110 Why?
Aged, 80 and over72020570230.110 Why?
Pituitary Neoplasms1201811830.110 Why?
Salvage Therapy1201712420.110 Why?
Diarrhea1201712820.100 Why?
Radiotherapy1201716780.100 Why?
Middle Aged1020202078600.100 Why?
Retrospective Studies72020613510.090 Why?
Orthopedic Procedures1201810910.090 Why?
Adult820202033850.090 Why?
Humans1620206483300.090 Why?
Survival Analysis22020105090.090 Why?
Risk Assessment22020224910.090 Why?
Aged820201545330.090 Why?
Female1120203597670.090 Why?
Male1020203390260.090 Why?
Neurosurgical Procedures1201717760.080 Why?
Thyroid Neoplasms1201819420.080 Why?
Molecular Targeted Therapy1201827150.080 Why?
Neoplasm Proteins1201837900.070 Why?
Breast Neoplasms22020187510.070 Why?
Prognosis52020275840.060 Why?
DNA-Binding Proteins1201897960.050 Why?
Young Adult42018527630.050 Why?
Genes, Retinoblastoma120181470.050 Why?
Heart Septal Defects120181740.040 Why?
Lung Neoplasms12020113480.040 Why?
Minor Histocompatibility Antigens120183070.040 Why?
Glutarates120182110.040 Why?
Prospective Studies12020460180.040 Why?
Treatment Outcome22020580890.040 Why?
Pregnancy Proteins120182940.040 Why?
Receptors, Progesterone1202010930.040 Why?
Integrases120185380.040 Why?
Cranial Irradiation120184310.040 Why?
Transgenes1201810230.040 Why?
Multivariate Analysis22020127210.040 Why?
Proportional Hazards Models22020120550.030 Why?
Risk Factors12020657890.030 Why?
BRCA1 Protein120209820.030 Why?
Isocitrate Dehydrogenase120187010.030 Why?
Estrogens1202014410.030 Why?
Tamoxifen120189640.030 Why?
Oxidation-Reduction1201822660.030 Why?
Hemoglobins1201814860.030 Why?
Enzyme Activation1201839790.030 Why?
Receptor, erbB-21202022120.030 Why?
Propensity Score1201716730.030 Why?
Recombinant Fusion Proteins1201839750.020 Why?
Referral and Consultation1202031260.020 Why?
Cause of Death1201833780.020 Why?
Kaplan-Meier Estimate1201968090.020 Why?
Homeostasis1201831860.020 Why?
Angiogenesis Inhibitors1201821090.020 Why?
Fibroblasts1201842860.020 Why?
Alleles1201869580.020 Why?
Follow-Up Studies22018384640.020 Why?
Adolescent32018813770.020 Why?
Echocardiography1201848680.020 Why?
Immunotherapy1201832170.020 Why?
Survival Rate12018131410.020 Why?
Cytokines1201868720.020 Why?
Cell Line, Tumor12018165810.010 Why?
Quality of Life1202098230.010 Why?
Disease Progression12017126600.010 Why?
Neoplasm Recurrence, Local1201779840.010 Why?
Mice, Inbred C57BL12018226210.010 Why?
Cohort Studies12019366420.010 Why?
Time Factors12017414510.010 Why?
Antineoplastic Agents12018135720.010 Why?
Mutation12018276620.010 Why?
Mice12018787360.010 Why?
Animals120181677580.000 Why?
Shi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (116)
Explore
_
Co-Authors (58)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.